Bio-Rad Laboratories, Inc. BIO.B Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $592.1M+1.1% | $693.2M+3.9% | $653M+0.5% | $651.6M+2.1% | $585.4M-4.2% | ||
| $282.7M+1.2% | $348M+6.9% | $309.6M+5.4% | $306.3M+8.1% | $279.4M-1.9% | ||
| $309.4M+1.1% | $345.2M+0.9% | $343.4M-3.5% | $345.3M-2.8% | $306M-6.1% | ||
| 52.3%0.0pp | 49.8%-1.4pp | 52.6%-2.2pp | 53%-2.6pp | 52.3%-1.1pp | ||
| $62.9M-14.4% | $70.3M-11.7% | $71.3M-21.6% | $60.5M+2.7% | $73.5M+10.7% | ||
| $212.4M+1.7% | $221M+8.3% | $206.8M+3.2% | $207.7M+6.7% | $208.8M-2.8% | ||
| $15M-2.0% | —— | $14.9M-4.5% | $11.9M-20.7% | $15.3M0.0% | ||
| $16.8M+5.0% | —— | $16.9M-2.3% | $17M+1.2% | $16M-11.6% | ||
| $34.1M+43.9% | —— | $65.3M+1.2% | $77.1M-24.0% | $23.7M-46.9% | ||
| 5.8%+1.7pp | —— | 10%+0.1pp | 11.8%-4.1pp | 4%-3.3pp | ||
| $12.3M+2.5% | $12.1M-0.8% | $12.3M+1.7% | $12.6M+2.4% | $12M-2.4% | ||
| $21M-42.0% | —— | $13.7M-11.0% | $14.7M-11.4% | $36.2M+6.5% | ||
| $24.2M-34.9% | $28.6M+45.9% | $8.3M-53.6% | $16.2M-11.0% | $37.2M+7.5% | ||
| $2.5M+400% | —— | $1M-50.0% | $900K+1,000% | $500K+350% | ||
| -$689.8M-927% | $929.2M+202% | -$431.1M-150% | $414M+115% | $83.4M-83.0% | ||
| -$162.7M-939% | $209.2M+208% | -$89.2M-143% | $96.2M+115% | $19.4M-81.9% | ||
| -$19.55-954% | $26.39+203% | -$12.70-154% | $11.67+115% | $2.29-83.0% | ||
| -$19.55-954% | $26.41+203% | -$12.70-154% | $11.67+115% | $2.29-83.0% | ||
| 27M-3.6% | 27.3M-3.3% | 26.9M-3.8% | 27.2M-4.1% | 28M-2.0% | ||
| 27M-3.5% | 27.3M-3.4% | 26.9M-3.7% | 27.2M-4.1% | 27.9M-2.0% | ||
| —— | $225.1M+134% | $225.1M+134% | $225.1M+134% | $225.1M+134% | ||
| $21M-42.0% | —— | $13.7M-11.0% | $14.7M-11.4% | $36.2M+6.5% | ||
| -$727.7M— | —— | —— | —— | —— | ||
| $15M-2.0% | —— | $14.9M-5.1% | $11.9M-20.7% | $15.3M0.0% | ||
| $100K+110% | —— | —— | -$600K-250% | -$1M-163% | ||
| $700K+75.0% | —— | $1M-50.0% | $400K-76.5% | $400K-66.7% | ||
| $5.9M+18.0% | —— | $7.3M+37.7% | $5.2M-1.9% | $5M-9.1% | ||
| 206K-15.6% | —— | 235K-8.6% | 504K+22.0% | 244K-30.5% | ||
| -$3.8M-163% | —— | $6.2M-65.7% | -$3.2M-152% | $6M-31.8% | ||
| -$23.2M-170% | —— | —— | -$151.4M— | $33.3M+13.3% | ||
| -$573.4M-398% | —— | -$354.6M-145% | $573.5M+126% | $192.4M-34.6% | ||
| $5.9M+428% | —— | —— | -$16.2M-526% | -$1.8M-167% | ||
| $0.24+1.3% | —— | $0.21-14.5% | $0.23+4.0% | $0.23+6.9% | ||
| -$8.4M-283% | —— | $1.8M-92.9% | -$2.4M+89.4% | $4.6M-62.6% | ||
| $300K0.0% | —— | $300K0.0% | $300K0.0% | $300K0.0% | ||
| $200K0.0% | —— | $200K0.0% | $200K0.0% | $200K0.0% | ||
| $100K0.0% | —— | $100K0.0% | $100K0.0% | $100K0.0% | ||
| $100K0.0% | —— | $100K0.0% | $100K0.0% | $100K0.0% | ||
| $2.4M-11.1% | $2.1M+10.5% | $2.9M+281% | -$1.1M-165% | $2.7M+35.0% | ||
| $5.9M+141% | —— | —— | -$30.3M-1,417% | -$14.4M-295% | ||
| -$2.7M-166% | —— | —— | $5.1M+829% | $4.1M+613% | ||
| -$2.7M-166% | —— | —— | $167M+23,957% | $4.1M+613% | ||
| $11M+39.2% | $7.3M-69.2% | $0-100% | $48.2M-0.4% | $7.9M+108% | ||
| $9.6M-67.8% | —— | —— | $4.7M— | $29.8M+167% | ||
| $166M+20,650% | —— | $88.4M— | -$69.5M-111% | $800K+101% | ||
| -$10.6M+3.6% | —— | -$11.3M-4.6% | -$11.7M-11.4% | -$11M-0.9% | ||
| $2M+142% | —— | -$1M-163% | $5.3M— | -$4.8M-1,100% | ||
| $0-100% | —— | $0-100% | $2K— | $14K-26.3% | ||
| $22.4M+0.9% | —— | $22.4M+0.4% | $900K0.0% | $22.2M-0.9% | ||
| -$738.2M-2,421% | —— | -$495.3M-162% | $334.4M+112% | $31.8M-92.5% | ||
| -$44M+55.0% | $0+100% | -$52.5M+45.3% | -$136.3M-41.1% | -$97.7M— | ||
| -$93.2M-3,314% | -$34.2M-12.1% | -$43M+22.8% | -$115.4M-273% | $2.9M+107% | ||
| $108.1M-16.8% | $164.9M+32.8% | $120.9M-26.1% | $116.5M+19.4% | $129.9M+86.1% | ||
| $1.7M— | —— | $0-100% | $0-100% | $0— | ||
| $6M+76.5% | —— | $1.8M— | $1.3M-69.8% | $3.4M-2.9% | ||
| $6.6M+144% | —— | $900K-74.3% | —— | $2.7M+17.4% | ||
| 2— | —— | —— | —— | —— | ||
| $10.6M-3.6% | —— | $11.3M+4.6% | $11.7M+11.4% | $11M+0.9% | ||
| $9.7M-4.0% | —— | $10M-2.0% | $10M-2.0% | $10.1M-5.6% | ||
| $500K— | —— | —— | —— | $0— | ||
| $500K— | —— | —— | —— | —— | ||
| $500K+150% | —— | -$500K-600% | $300K-40.0% | $200K+114% | ||
| $1.1M— | —— | —— | —— | $0— | ||
| -$40.9M-133% | —— | -$14.7M-112% | $254.5M+1,130% | $123.6M+235% | ||
| -$46.3M-136% | —— | -$12.7M-109% | $255.7M+1,107% | $128.4M+243% | ||
| -$46.3M-136% | —— | -$12.7M-109% | $255.7M+1,107% | $128.4M+243% | ||
| -$6M-220% | —— | $1.5M-88.6% | $1.5M+850% | $5M+1,150% | ||
| $40.9M+7.3% | —— | $44.2M+13.6% | $40.6M+11.5% | $38.1M+2.7% | ||
| $700K+40.0% | —— | $1M+100% | $600K-64.7% | $500K-37.5% | ||
| $24.2M-34.9% | $28.6M+45.9% | $8.3M-53.6% | $16.2M-11.0% | $37.2M+7.5% | ||
| $47.8M-53.1% | $0— | $53.4M-45.5% | $140.2M+38.8% | $101.9M+2,068% | ||
| $226.1M+47.4% | $138.8M-37.7% | $223.9M-43.9% | $153.2M-38.2% | $153.4M-62.3% | ||
| $30M-12.8% | $45.8M+6.8% | $31.7M-21.1% | $45.7M+8.0% | $34.4M-14.4% | ||
| $515.8M+5.7% | $547.5M+3.9% | $517.5M+15.9% | $505.9M-3.6% | $488M-12.9% | ||
| -$9.9M-219% | —— | $8.6M-45.6% | $26M+386% | $8.3M+477% | ||
| $614.1M-4.0% | $697.7M+10.4% | $653.8M-0.3% | $664.9M+6.0% | $640M+0.3% | ||
| $3.4M-20.9% | —— | $3.4M-33.3% | $4.2M-10.6% | $4.3M-21.8% | ||
| $17.7M-9.2% | $3M-89.9% | $13.8M-68.0% | $25.7M-52.7% | $19.5M-73.0% | ||
| $33.3M+104% | $18.3M-3.7% | $13.8M-14.3% | $32.6M-7.4% | $16.3M+3.2% | ||
| $145.1M-15.2% | $147.4M-28.3% | $200.6M-44.9% | $274.4M+33.9% | $171.2M-48.4% | ||
| $100K— | —— | —— | $100K+35.1% | $0-100% | ||
| $1.9M+35.7% | —— | $1.8M+5.9% | $1.3M-23.5% | $1.4M-39.1% | ||
| $2.8M+180% | —— | $1.9M+5.6% | $800K-60.0% | $1M-28.6% | ||
| $2.5M+400% | —— | $1M-50.0% | $900K+1,000% | $500K+350% | ||
| $100K0.0% | $200K— | $0-100% | $200K+100% | $100K-50.0% | ||
| 3%0.0% | —— | 3%0.0% | 3%0.0% | 3%0.0% | ||
| $592.1M+1.1% | —— | $653M+0.5% | $651.6M+2.1% | $585.4M-4.2% | ||
| $2.3M+9.5% | —— | $1.7M+1,600% | $38M+927% | $2.1M-72.4% | ||
| $3.4M-20.9% | —— | —— | $4.2M-10.6% | $4.3M-21.8% | ||
| $500K-50.0% | —— | $500K-50.0% | $1.4M+40.0% | $1M+2,028% | ||
| $47.3M-53.1% | —— | $52.9M-45.4% | $138.8M+38.8% | $100.9M+2,047% | ||
| $8.8M+29.4% | —— | $4M— | $12M-42.3% | $6.8M+423% | ||
| -$4.6M-229% | —— | -$4.4M— | $800K— | -$1.4M— | ||
| $34.1M+43.9% | $941.3M+1,515% | $65.3M+1.2% | $77.1M-24.0% | $23.7M-46.9% | ||
| $80.9M+21.1% | —— | $116.8M+7.5% | $122.9M-14.2% | $66.8M-23.4% | ||
| $80.9M+21.1% | —— | $116.8M+7.5% | $122.9M-14.2% | $66.8M-23.4% | ||
| 13.7%+2.3pp | —— | 17.9%+1.2pp | 18.9%-3.6pp | 11.4%-2.9pp | ||
| $34.1M+43.9% | $941.3M+1,515% | $65.3M+1.2% | $77.1M-24.0% | $23.7M-46.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Bio-Rad Laboratories, Inc.'s revenue?
- Bio-Rad Laboratories, Inc. (BIO.B) generated $2.6B in revenue over the trailing twelve months, up 1.9% year over year.
- Is Bio-Rad Laboratories, Inc. profitable?
- Bio-Rad Laboratories, Inc. reported $168.8M in net income over the trailing twelve months, a 6.5% net margin.
- What are Bio-Rad Laboratories, Inc.'s profit margins?
- Gross margin is 51.9% and operating margin is 8.8%, with a 6.5% net margin.
- What is Bio-Rad Laboratories, Inc.'s earnings per share?
- Bio-Rad Laboratories, Inc.'s diluted EPS over the trailing twelve months is $5.81.
- Where does Bio-Rad Laboratories, Inc.'s income statement data come from?
- Every line is extracted from Bio-Rad Laboratories, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
